Cybin (HELP) Change in Accured Expenses (2020 - 2025)
Cybin's (HELP) quarterly Change in Accured Expenses came in at $2.8 million in Q4 2025, down 35.15% YoY from $4.3 million in Q4 2024, and up 336.44% on a QoQ basis from -$1.2 million in Q3 2025.
Cybin (HELP) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Cybin (HELP) has 6 years of Change in Accured Expenses data on file, last reported at $2.8 million in Q4 2025.
- Quarterly Change in Accured Expenses fell 35.15% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (up 272.82% YoY) and the FY2023 annual result came in at -$855934.0, down 134.24% from the prior year.
- Change in Accured Expenses climbed to $2.8 million in Q4 2025, from -$1.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $4.3 million in Q4 2024 to a low of -$5.7 million in Q4 2023.
- A 5-year average of $120243.9 and a median of $210703.5 in 2021 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses soared 1329.3% — and 2024, when it slumped 1620.53%.
- Tracing HELP's Change in Accured Expenses over 5 years: stood at $330027.8 in 2021, then plunged by 214.51% to -$377928.6 in 2022, then plunged by 1414.63% to -$5.7 million in 2023, then soared by 175.86% to $4.3 million in 2024, then slumped by 35.15% to $2.8 million in 2025.
- The last three Change in Accured Expenses figures came in at $2.8 million (Q4 2025), -$1.2 million (Q3 2025), and -$347000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -347,000.00 |
| Jun 30, 2025 | -347,000.00 |
| Dec 31, 2024 | 4.34 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Dec 31, 2023 | -5.72 Mn |
| Dec 31, 2023 | -5.72 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 250,136.03 |
| Jun 30, 2023 | 250,136.03 |
| Feb 28, 2023 | -170,709.66 |
| Feb 28, 2023 | -170,709.66 |